The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Evidence · Journal club

Journal club: SELECT, absolute risk, and how it was reported

MS
m.stephanopoulosTL3Regular22 Apr 2026#1

Journal club: SELECT, absolute risk, and how it was reported Writing it up because I had to work it out twice and would rather nobody else did.

A question about what the numbers mean rather than what they are.

SELECT (N Engl J Med, 2023) reports its primary result in relative terms, and the absolute figures are in a table two pages later. The two produce very different impressions of the same finding.

I would like to work through which one belongs in a summary, and why the answer is not simply "both".

44 likes 3mo
FV
f.villalobosTL228 May 2026 · edited#2

SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular argument from glucose control. Read the absolute numbers, not just the relative reduction.

Reading it again, the caveat matters more than the finding.

11 likes 2mo
JF
j.fonsecaTL223 Jun 2026#3

Coming back to the opening post, because the follow-up matters more than the original answer.

Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your population to apply the results? (4) What was the absolute effect, not just the relative one? (5) What are the two strongest criticisms available?

1 like 1mo

Suggested topics

TopicParticipantsRepliesViewsActivity
[2026 update] Journal club: FLOW and the renal composite, component by component
Journal club: FLOW and the renal composite, component by component Writing it up because I had to work it out twice and would rather nobody else did. A question about what the numbers mean rather than what…
NBTAC 2 21k 9d
Journal club: FLOW and the renal composite, component by component
On the subject in the title: Journal club: FLOW and the renal composite, component by component Working notes rather than a conclusion. Reading FLOW ( N Engl J Med , 2024) for the population rather than the…
ACNNZLHEAW+84 91 18k 2y
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field
Posting this under the heading it deserves: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Everything below is what sits behind that. Collecting what is known about SURMOUNT-OSA in one place,…
CIRCBPMN+47 51 617 16mo
Journal club: SURMOUNT-4 and continuation versus withdrawal
Journal club: SURMOUNT-4 and continuation versus withdrawal — setting out what I have, and where I think it stops being reliable. Trying to establish the boundary conditions on SURMOUNT-4 and continuation…
ZNVDTTBMA+32 36 31k 3mo
Journal club: orforglipron phase 2 and the non-peptide question
Journal club: orforglipron phase 2 and the non-peptide question Writing it up because I had to work it out twice and would rather nobody else did. Orforglipron phase 2, and specifically the version of it that…
KBLKSSJLB+120 132 13k 1d

Related topics — sharing the tags journal club, estimand, randomised trial

TopicParticipantsRepliesViewsActivity
Coming back to: Prediction intervals and why they are more honest than confidence intervals
Prediction intervals and why they are more honest than confidence intervals Writing it up because I had to work it out twice and would rather nobody else did. Prediction intervals — I have the observation and…
TDIBB 2 65 22mo
When a network meta-analysis is defensible and when it is not
When a network meta-analysis is defensible and when it is not I have a specific reason for asking rather than idle curiosity, and the context is below. Network meta-analysis, from the point of view of someone…
MVMBC 2 27k 4h
An ABAB design with a data table and honest limitations
An ABAB design with a data table and honest limitations Writing it up because I had to work it out twice and would rather nobody else did. An honest uncertainty about ABAB design rather than a disguised…
SSDSEF 2 45k 5mo
Journal club: is percentage weight change the right endpoint?
Journal club: is percentage weight change the right endpoint? I have a specific reason for asking rather than idle curiosity, and the context is below. Bringing a claim rather than a paper, because the claim…
IFLEDSSBE+116 120 23k 3mo
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction — one year on
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction — one year on — that is the question, and I have not found it answered plainly anywhere I have looked. The question about…
EHSBBOARB+3 7 1k 2mo